GSK discontinues Stelazine
Executive Summary
Stelazine (trifluoperazine) is being pulled from the market because of generic availability, GlaxoSmithKline says. Stelazine will be off the market by Jan. 31, 2004. Final lots of the psychiatric product were distributed in August 2003...